Sumitomo Pharma Co., Ltd. (DNPUF)

Sumitomo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	5,832	1,934	1,045	2,421	3,952	6,922
Market Cap Growth	325.41%	85.01%	-56.82%	-38.75%	-42.91%	33.63%
Enterprise Value	7,126	3,864	3,527	2,604	4,995	8,376
Last Close Price	12.88	4.76	2.40	6.38	10.22	18.75
PE Ratio	8.31	12.26	-	-	8.51	13.62
PS Ratio	2.02	0.73	0.50	0.58	0.86	1.48
PB Ratio	3.16	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	19.42	36.19	-	92.74	20.09	5.91
P/OCF Ratio	17.16	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	2.45	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	8.52	15.00	-	-	6.17	12.04
EV/EBIT Ratio	10.22	44.43	-	-	10.12	17.06
EV/FCF Ratio	23.73	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.90	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.99	8.14	-	-	2.89	3.78
Debt / FCF Ratio	5.50	39.27	-	99.82	11.91	2.24
Asset Turnover	0.54	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.95	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.91	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.40	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	48.39%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	8.13%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Invested Capital (ROIC)	22.11%	2.56%	-60.99%	-18.52%	3.91%	3.23%
Return on Capital Employed (ROCE)	18.00%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	12.04%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	5.15%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.48%	2.26%	1.35%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.48%	2.26%	1.35%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.